Experienced in Peripheral Neuropathy

Zakaria Einbeigi

Boras, O, SE 
Experienced in Peripheral Neuropathy
Boras, O, SE 
OverviewLocationsClinical Research

Overview

Zakaria Einbeigi practices in Boras, Sweden. Mr. Einbeigi is rated as an Experienced expert by MediFind in the treatment of Peripheral Neuropathy. His top areas of expertise are Breast Cancer, Ring Chromosome 12, Ovarian Cancer, Peripheral Neuropathy, and Mastectomy.

His clinical research consists of co-authoring 43 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Peripheral Neuropathy.

Gender
Male

Locations

Boras, O, Sweden
Other Locations
Goeteborg, O, Sweden
41345, Sweden

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Translational Randomized Phase III Study Exploring the Effect of the Addition of Capecitabine to Carboplatine Based Chemotherapy in Early Triple Negative Breast Cancer
A Translational Randomized Phase III Study Exploring the Effect of the Addition of Capecitabine to Carboplatine Based Chemotherapy in Early Triple Negative Breast Cancer
Enrollment Status: Active_not_recruiting
Publish Date: September 12, 2025
Intervention Type: Drug
Study Drugs: epirubicin, cyclophosphamide, paclitaxel, carboplatin, capecitabine
Study Phase: Phase 3
PREDIX HER2 - Neoadjuvant Response-guided Treatment of HER2 Positive Breast Cancer. Part of a Platform of Translational Phase II Trials Based on Molecular Subtypes
PREDIX HER2 - Neoadjuvant Response-guided Treatment of HER2 Positive Breast Cancer. Part of a Platform of Translational Phase II Trials Based on Molecular Subtypes
Enrollment Status: Active_not_recruiting
Publish Date: August 13, 2020
Intervention Type: Drug
Study Drugs: docetaxel, trastuzumab sc, pertuzumab, trastuzumab emtansin
Study Phase: Phase 2/Phase 3
View 1 Less Clinical Trial

43 Total Publications

Randomised trial of trastuzumab deruxtecan and biology-driven selection of neoadjuvant treatment for HER2-positive breast cancer: a study protocol of ARIADNE.
Randomised trial of trastuzumab deruxtecan and biology-driven selection of neoadjuvant treatment for HER2-positive breast cancer: a study protocol of ARIADNE.
Journal: BMJ open
Published: August 27, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Einbeigi's expertise for a condition
ConditionClose
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile